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Commentary
Expanding the uses of genome-scale
models with protein structures
Nathan Mih1,2 & Bernhard O Palsson1,3
Biology is reaching a convergence point of
its historic reductionist and modern holistic
approaches to understanding the living
system. Structural biology has historically
taken the reductionist approach to deeply
probe the inner workings of complex mole-
cular machines. In contrast, systems biology
and genome-scale modeling have organi-
cally grown out of the wealth of data now
being generated by diverse omics measure-
ments. In the late 2000s, a proposed inter-
disciplinary field of structural systems
biology pitched the merger of these two
approaches, with widespread applications in
pharmacology, disease modeling, protein
engineering, and evolutionary studies. In
this commentary, we highlight the chal-
lenges of integrating these two fields, with a
focus on genome-scale metabolic modeling,
and the novel findings that are made
possible from such a merger.
A challenge for converging fields
T he field of structural systems biologyrepresents an integration of twoestablished, but quite different, fields:
structural biology and systems biology.
Given the different histories, underlying
paradigms, ways of thinking, and the char-
acteristics of the data types used in these
two fields, such an integration is not without
its challenges. In spite of these fundamental
differences, a convergence is not only
happening, but is necessary to achieve the
ultimate goals of systems biology.
The number of experimental structures in
the Protein Data Bank (PDB) continues to
steadily rise each year. A key distinction
between structural data and the omics data
types prevalent in systems biology is the capa-
bility of structural data to “zoom in” to the
atomic level to study fundamental details of
chemical interactions. A structural biologist
knows the value of mechanistic insights that
can be gained from this information. Struc-
tural data offer new features, such as a three-
dimensional context to mutations, post-trans-
lational modifications, protein domains, link-
ing needs for functionalizing prosthetic groups
to metabolism, ROS damage sites, and others,
enabling the execution of novel studies in
systems biology. We have now reached the
point where structural information for certain
organisms, such as Escherichia coli and Homo
sapiens, can be utilized at the systems level.
In contrast to structural biology, a systems
biologist “zooms out” to see thousands of
biomolecular interactions happening simultane-
ously. The totality of such interactions is experi-
mentally studied through the generation of
various omics data types and by constructing
large-scale mechanistic frameworks to relate
individual components represented in such data
sets. The success of genome-scale metabolic
modeling can be attributed to high-quality,
bottom-up reconstructions of metabolic, protein
synthesis, and transcriptional regulatory
networks on an organism-specific basis.
What does systems biology need from
structural biology?
To understand how structural biology can
be utilized like an additional omics data
source in systems biology, we first describe
how we use the terms “structural genomics”
and “structural proteomics”. Structural
genomics has widely been used to describe
the determination of all 3D structures of
proteins within an organism’s genome.
Worldwide collaborations have led to the
deposition of over 150,000 structures in the
PDB, and novel protein folds and families
have been uncovered as a result of this
exhaustive effort. With systems biology
models, there is a clear benefit to having this
information available, making accessible a
literal new dimension of information to
describe the components of a cell down to
the molecular level.
However, knowing just the 3D struc-
tures of proteins is only one-half of what is
needed to fully realize structural data as an
omics data type. The term structural
proteomics has increasingly been used to
describe novel experimental approaches for
determining the millions of transient inter-
actions between proteins and other compo-
nents of the cell (Piazza et al, 2018). Thus,
we can attempt to delineate the two terms,
with one being defined as the study of
what is encoded and produced directly
from the genome (structural genomics) and
the other as the result of these encoded
components interacting with their environ-
ment (structural proteomics). Yet, there is
no clear separation between the two terms
as structural determination technologies
advance—in particular, in-cell NMR tech-
niques actually resolve structures at an
atomic level within a cell (Tanaka et al,
2019), while cryo-electron tomography
(cryo-ET) promises to answer both ques-
tions of structures and interactions by visu-
alizing all components interacting with
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each other at a point in time (Beck &
Baumeister, 2016). For clarity, in this
commentary we will simply refer to the
overall collection of protein structures in
the context of systems models as the struc-
tural proteome.
With these data sets becoming commonly
available, new computational and data chal-
lenges arise. Computational tools are
required for numerous integration problems,
such as for putting together the pieces of
higher-order protein complexes, filling in the
gaps of missing structures and interactions
with in silico predictions, and formally inte-
grating data derived from this information
within systems models. None of these are
trivial problems to solve, but recent
advances in all these areas encourage us that
this future is not too far away.
Adding protein structures to genome-
scale metabolic models
In 2009, a structural genomics project for
the thermophile Thermotoga maritima was
completed. At the same time, a newly
reconstructed metabolic network of
T. maritima provided the context with
which to analyze this compendium of
protein structures (Zhang et al, 2009). This
pioneering study created the first genome-
scale model with protein structures, or
GEM-PRO. With this integrated model, the
authors addressed questions associated
with the evolution of new pathways in a
metabolic network, focusing on two
competing theories of pathway evolution.
One theory posited that functionality
evolves by the recruitment of nearby
neighbors in a metabolic pathway that are
likely to carry out similar enzymatic
changes. Another theory stated that func-
tionality evolved through the recruitment
of promiscuous enzymes from faraway
parts of a metabolic network to carry out
the next steps of a pathway. By looking at
the protein folds in the context of a
network, it was found that folds were
quite different compared to neighboring
enzymes, leading to the conclusion that
functionality likely evolved through the
second, promiscuous recruitment model
(Fig 1C). This study demonstrated that a
synergy between structures and their loca-
tion in a network was required to answer
an evolutionary question. If the structures
were the only source of information avail-
able, it would not be possible to
understand their position within a meta-
bolic network. At the same time, with just
a metabolic network, no knowledge of the
protein folds in 3D space would be avail-
able.
The integration of structural data into
metabolic models has subsequently been
extended to a number of applications, which
we categorize and review below.
The composition, biosynthesis, and
visualization of proteins
Similar to how genome content can be
summarized by their nucleotide building
blocks, the structural proteome of an organ-
ism can be described in terms of the
biochemistry of its proteins and their amino
acid composition. Simple physicochemical
properties (polarity, hydrophobicity, size)
can act as descriptors, and more detailed
spatial information such as location and
function can be included—given a character-
ized 3D structure of the protein (Fig 1A).
These data can be prepared for downstream
data science analyses and can further
enhance modeling capabilities by introduc-
ing quantitative predictions of enzyme activ-
ity based on these properties at different
stress conditions.
How does a cell determine its alloca-
tion of resources to the variety of machin-
ery that drives its growth and maintains
its functions? A new generation of
genome-scale metabolic models incorporate
the cost of synthesizing the enzymes that
carry out metabolic reactions in a cell.
Enzyme turnover rates then become
crucial pieces of information that need to
be curated or estimated for all of a
model’s reactions. Recently, we turned to
structural information to aid in the predic-
tion of these notoriously hard to estimate
rates, using machine learning methods for
a proteome synthesis model of E. coli
(Heckmann et al, 2018). Structural features
describing the active sites of these
enzymes and general descriptors of the
global protein structure were incorporated
alongside a number of other features into
the predictive model.
The structure–function relationship also
provides fundamental information for
describing an enzyme’s role within a meta-
bolic network. As more and more struc-
tures are solved, similarities between them
and well-studied proteins allow us to confi-
dently assume functionalities when
reconstructing metabolic networks. As we
approach the completion of these features,
large-scale visual representation becomes
possible. What may be viewed as the
“final frontier” of structural systems biol-
ogy would be an accurate visual 3D model
of a cell, incorporating all known molecu-
lar interactions, localizations, abundances,
enzyme complex stoichiometries, higher-
order DNA structures, small molecules,
and more (Fig 1B). New work with cryo-
electron tomography has begun to uncover
the assemblies of higher-order protein
complexes in their native environment
(Beck & Baumeister, 2016). This promises
to provide a visual connection between
proteomics measurements and individually
solved structures. Furthermore, it is now
possible to obtain atomic-level NMR struc-
tures of enzymes in these native environ-
ments—the final piece of the puzzle
needed to view the components of a cell in
their natural state, in vivo (Tanaka et al,
2019). Systems biology models provide the
platform onto which these types of data
can be mapped and represented computa-
tionally.
A predictive and visual model of
proteome allocations under different condi-
tions remains a challenge, as it is no small
undertaking to manually gather and recon-
struct enzymatic pathways, let alone simu-
late these models of growing complexity.
The big picture of small changes
How do protein changes at the residue level
impact the metabolic network and pheno-
typic behavior as a whole? Can the totality
of these changes help classify cell types in
humans or delineate between species and
strains of unicellular organisms?
As a proof-of-concept, molecular model-
ing tools were used to analyze the impact
of coding mutations on drug binding in
the human red blood cell (Fig 1D; Mih
et al, 2016). Docking and molecular
dynamics simulations enabled predictions
of differences in the binding affinities of
small molecules due to a mutation in
selected proteins. These relative differences
were integrated into both constraint-based
and kinetic metabolic models of the red
blood cell to observe the predicted
systemic impact of the mutation upon
metabolism. Sequence variation can also
be mapped from different strains of a
species, different species altogether, or
2 of 5 Molecular Systems Biology 15: e8601 | 2019 ª 2019 The Authors
Molecular Systems Biology Nathan Mih & Bernhard O Palsson
from different cell lines (Fig 1E). Combined
with spatial descriptors of amino acids,
this approach can pinpoint certain protein
domains with causal mutations that cluster
together. The sequence variation of G-
protein-coupled receptors (GPCRs) is a
likely reason behind adverse effects that
are observed in a minority of individuals
who take a certain drug (Hauser et al,
2018). A comprehensive effort to map
this variation from almost 70,000 individ-
uals revealed numerous variants that
appear close to drug binding pockets or
other functional sites on GPCRs. Certain
drug labels already include such warnings
for characterized variants if an adverse
reaction is known to occur, and this
personalized information can only
improve as more interaction data are
gathered.
Extending these approaches to new meth-
ods such as those that attempt to model
strain-specific metabolism, we can begin to
simulate differences at the resolution of single
amino acids. Machine learning algorithms
can take advantage of this information to
identify patterns of genetic changes due to
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certain stresses, such as drug-resistant strains
of pathogens, and be used to develop predic-
tive models for newly sequenced strains.
The new era of multi-omics data
The study of interactions between proteins
and small molecules has largely been limited
to those directly related to catalysis, studied
with enzymatic assays. A large-scale under-
standing of all small molecule interactions
with proteins inside a cell adds yet another
interactome to systems biology models,
uncovering competitive and non-competitive
interactions that regulate processes alongside
the transcriptome (Fig 1F).
Early work in this area focused on
predicting the effects of small molecules
binding to undesired targets, also known as
off-targets. A human kidney metabolic
model integrated with structural information
was used to reveal the potential mechanism
of action of torcetrapib, a drug that was in
development to treat high cholesterol levels
(Chang et al, 2010). Retrospectively, this
approach was utilized to give potential
explanations as to why the drug gave rise to
fatal hypertension in patients during clinical
trials. This study applied binding site simi-
larity predictions to human protein struc-
tures to identify potential targets that this
drug could inhibit in addition to its main
target. By combining these predictions with
gene knockouts in a metabolic model of the
human kidney, the authors were able to
predict the clinically observed hypertension
as a potential side effect of these off-target
binding events.
Experimental data sets representing these
transient interactions with protein molecules
are beginning to take shape. For the
metabolome, ingenious techniques that
apply proteolytic and mass spectrometric
methods mean that protein–small molecule
interactions can be elucidated at a scale
comparable to other omics methods (Piazza
et al, 2018). An additional layer of informa-
tion can be added by measuring the effects
of gene deletions on metabolite levels, in
what are known as gene–metabolome data
sets (Fuhrer et al, 2017). For the other large
molecules within the cell, a number of
biomolecular interaction screens are avail-
able and should be next in line to be explic-
itly accounted for in structural systems
biology models. These include protein–
protein interaction techniques and data sets,
which not only provide information about
protein complex compositions but also intro-
duce cell signaling into the mix. The DNA
interactome can be deciphered through
protein–DNA interactions as measured by
methods such as ChIP-exo and predicted
with newly developed algorithms that take
into account the 3D structure of DNA motifs
(Chiu et al, 2017).
Taking all of this information together
and distilling it into a snapshot of a cell at
work is perhaps the biggest challenge of
them all, as data sets balloon in size when
considering the billions, perhaps trillions, of
interactions—all occurring at once.
What lies ahead for structural
systems biology?
The number of studies presented here
demonstrates the growing range of applica-
tions enabled by the inclusion of protein
structures into network models of metabo-
lism, proteome synthesis, and proteostasis.
We can now comfortably state that the
structural proteome is now an available
independent omics data type that (i) can be
assembled for model organisms, (ii) can be
computationally represented and integrated
into genome-scale models, and (iii) adds
new dimensions to systems biology studies
where a fundamentally new set of questions
can be addressed. Although we are still far
from realizing a fully integrated multi-scale
whole-cell model, these studies show that
even with incomplete information, the
continued development and application of
structural systems biology leads to novel
applications.
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